Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer
Benderli Cihan, Y.
Journal of Buon Official Journal of the Balkan Union of Oncology 23(6): 1931-1932
2018
ISSN/ISBN: 1107-0625 PMID: 30610829 Document Number: 696435
Document emailed within 1 workday
Related Documents
Zubova, S.G.; Bykova, T.V. 2015: Regulation of the Mtor Signaling Pathway in Macrophages in Various Pathologies Tsitologiia 57(11): 755-760Sugiyama, M.; Takahashi, H.; Hosono, K.; Endo, H.; Kato, S.; Yoneda, K.; Nozaki, Y.; Fujita, K.; Yoneda, M.; Wada, K.; Nakagama, H.; Nakajima, A. 2009: Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway International Journal of Oncology 34(2): 339-344
Brown, R.E. 2004: Morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma Annals of Clinical and Laboratory Science 34(4): 397-399
Lin, F.; Zhang, P.L.; Yang, X.J.; Prichard, J.W.; Lun, M.; Brown, R.E. 2006: Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas Annals of Clinical and Laboratory Science 36(3): 283-293
Xu, J.; Wu, C.-l.; Huang, J. 2015: Effect of celastrol in inhibiting metastasis of lung cancer cells by influencing Akt signaling pathway and expressing integrins Zhongguo Zhong Yao Za Zhi 40(6): 1129-1133
Aguado, M.T.; Perrin, L.H.; Ramirez, R.; Miescher, P.A.; Lambert, P.H. 1980: Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins Clinical and Experimental Immunology 42(3): 495-505
Zhang, Y.; Wu, Z.-M.; Lei, B.-H.; Lu, Z.-J.; Zhu, Q.-Y.; Xu, F.-S.; Zhang, M.-S.; Liu, P. 2017: Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway Zhonghua Nan Ke Xue 23(9): 828-837
Ma, Q.; Chang, Z.; Wang, W.; Wang, B. 2015: Rapamycin-Mediated mTOR Inhibition Reverses Drug Resistance to Adriamycin in Colon Cancer Cells Hepato-Gastroenterology 62(140): 880-886
Iżycka-Świeszewska, E.; Wesołowski, W.; Hermann, B. 2015: Extracardiac rhabdomyomas--presentation of two cases with analysis of AKT/mTOR and ERK1/2 signaling Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 66(2): 195-199
Weeber, F.; Koudijs, M.J.; Hoogstraat, M.; Besselink, N.J.M.; VAN Lieshout, S.; Nijman, I.J.; Cuppen, E.; Offerhaus, G.Johan.; Voest, E.E. 2015: Effective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComa: A Case Report Anticancer Research 35(6): 3399-3403
Price, S.R.; Bailey, J.L.; England, B.K. 1996: Necessary but not sufficient: the role of glucocorticoids in the acidosis-induced increase in levels of mRNAs encoding proteins of the ATP-dependent proteolytic pathway in rat muscle Mineral and Electrolyte Metabolism 22(1-3): 72-75
Tsujimura, K.; Nakashima, K. 2017: Novel function of MeCP2 in the pathophysiology of Rett syndrome: Regulation of mTOR signaling mediated by MeCP2-dependent microRNA processing Seikagaku. Journal of Japanese Biochemical Society 89(1): 51-61
Xu, D.; Barbour, M.; Jiang, H.-R.; Mu, R. 2019: Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases Clinical and Experimental Rheumatology 37 Suppl 119(4): 141-146
Barndt, R.; Dai, M.F.; Zhuang, Y. 1999: A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis Journal of Immunology 163(6): 3331-3343
Kao, X.-b.; Gao, Y.; Chen, J.-h.; Chen, Q.; Wang, Z.-l.; Wang, Z. 2013: Role of JNK signaling pathway in chondrocyte apoptosis induced by nitric oxide Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 31(4): 271-275
Yang, J.; Yin, H.; Zhang, Y.; Yan, Z.; Fu, H.; Zhu, Y. 2019: Role of Hippo signaling pathway in mice hypospadias induced by vinclozolin Wei Sheng Yan Jiu 48(4): 615-620
Kim, D.T.; Mitchell, D.J.; Brockstedt, D.G.; Fong, L.; Nolan, G.P.; Fathman, C.G.; Engleman, E.G.; Rothbard, J.B. 1997: Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide Journal of Immunology 159(4): 1666-1668
Hudes, G.R. 2007: MTOR as a target for therapy of renal cancer Clinical Advances in Hematology and Oncology: H&o 5(10): 772-774
Haziot, A.; Lin, X.Y.; Zhang, F.; Goyert, S.M. 1998: The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent Journal of Immunology 160(6): 2570-2572
Tan, J.S.J.; Ong Kc, K.C.; Rhodes, A. 2016: The role of heat shock proteins and glucose regulated proteins in cancer Malaysian Journal of Pathology 38(2): 75-82